FSFeyzi Birol Sarica

Feyzi Birol Sarica

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Feyzi Birol Sarica has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Surgical Principles for Spinal Meningiomas

    by Feyzi Birol Sarica

    Spinal meningiomas, which are usually benign character, rarely show an invasive course. Since they grow slowly in the intradural extramedullary space, clinical symptoms also progress slowly. It is usually diagnosed in the later periods, when the tumor reaches to large size. They most commonly show location in the thoracic region. Although it does not have a real capsule, they can be removed completely or close to total by microsurgical methods, since they are well-demarcated solitary tumors. The most important factor in the complete and safe removal of spinal meningioma is the selection of the surgical approach suitable for the size, localization, and topography of the tumor. In the postoperative period, improvement in neurological functions is observed generally and their prognosis is good. In this study, the natural history of the tumor is explained in detail, by examining the pathogenesis and predisposing factors and clinical symptomatology in the spinal meningiomas. Moreover, it has been also focused on describing the surgical approaches and operative techniques to be used in the complete and safe removal of the spinal meningioma, according to the localization and topography of the tumor.


  • Open Access

    Surgical Principles for Spinal and Paraspinal Neurofibromas

    by Feyzi Birol Sarica

    Neurofibromas are the most prevalent seen tumor in the neurofibromatosis type 1 (NF1) disease. Spinal neurofibromas, which are the major diagnostic criteria of disease, are seen in approximately 60% of the patients with NF1. They constitute 23% of all of the spinal tumors. While the spinal neurofibromas most frequently show a location in thoracic region, it is followed by their predilection in cervical and lumbar regions, respectively. The spinal neurofibromas located in the sacral region are quite rarely observed and show an asymptomatic course until reaching to the big sizes. Of these spinal neurofibromas, 72% were with intradural extramedullary, 14% with extradural, and 13% with intradural and extradural “dumbbell formation.” Only 1% of the spinal neurofibromas are intramedullary located. The total taking of the single solitary neurofibroma surgically is relatively easier. But, the difficulties can be encountered in taking these tumors surgically since they are characterized by the multiple tumors in the plexiform neurofibromas, especially accompanying to the NF1. In this chapter, the surgical difficulties encountered in the region in which the tumor is localized and different surgical approaches are developed in the course of time in order to exceed these difficulties are described.


  • Open Access

    Delayed radiation myelopathy: Differential diagnosis with positron emission tomography/computed tomography examination

    by Tufan Kadir, Feyzi Birol Sarica, Kardes Ozgur, Melih Cekinmez, Altinors Mehmet Nur

    Myelopathy is a rare but serious complication of radiation therapy (RT). Radiation myelopathy is white matter damage to the spinal cord developed after a certain period of application of ionizing radiation. Factors such as radiation dose and time between applications affect the occurrence as well as the severity of myelopathy. In those patients, positron emission tomography/computed tomography examination has a very important role both in the diagnosis and in the differential diagnosis of lesions. In this case report, the case of progressive paraparesis, developed in a 52-year-old female patient operated with pulmonary mucinous cystadenocarcinoma diagnosis and who received chemotherapy and RT following surgery, has been reported.


  • Open Access

    Five-year follow-up results for patients diagnosed with anaplastic astrocytoma and effectiveness of concomitant therapy with temozolomide for recurrent anaplastic astrocytoma

    by Feyzi Birol Sarica, Melih Cekinmez, Orhan Sen, Huseyin C Onal, Huseyin Mertsoylu, Berrin Pehlivan, Bulent Erdogan, Mehmet N Altinors, Kadir Tufan, Erkan Topkan

    Background: Anaplastic astrocytoma (AA; WHO grade-III) patients determination of prognostic factors helps generating multimodal therapy protocols. For this purpose, in the Baskent University, Adana Medical Research Center, specific characteristics of AA patients who have surgery were retrospectively investigated and factors which affect prognosis has been determined. Patients and Methods: Between January 2005 and 2009, 20 patients who have AA have been evaluated retrospectively. Totally, 20 patients had 31 operations. Sixteen patients had only adjuvant radiation therapy (RT). In the postoperative period, 8 patients received adjuvant RT. Nine of 10 patients with tumor recurrence received concomitant therapy with temozolomide (ConcT with TMZ) protocol. No adjuvant therapy protocol could be applied in three patients with poor general condition in the postoperative period. Results: Median survival for patients died was 16±17 months; one year survival was 75% and five year survival 25%. After univariate analysis, preoperative Karnofsky performance score (KPS) was ≥80 ( P=0.005577*), postoperative KPS was ≥80 ( P=0.003825*), type of tumor resection ( P=0.001751*), multiple operations ( P=0.006233*), and ConcT with TMZ protocol ( P=0,005766*) were all positive prognostic factors which extend the survival. Conclusions: The results of the multivariate analysis did not put forward an independent prognostic factor acting on the survival period ( P>0.05).


    • 1 March 2010
      • Vol. 54  (1) , 7-19

    Effectiveness of temozolomide treatment used at the same time with radiotherapy and adjuvant temozolomide; concomitant therapy of glioblastoma multiforme: multivariate analysis and other prognostic factors.

    by F Birol Sarica, K Tufan, M Cekinmez, O Sen, H Cem Onal, H Mertsoylu, E Topkan, B Pehlivan, B Erdogan, M Nur Altinors

    Prognostic factors which affect treatment results of glioblastoma multiforme (GBM; WHO Grade IV) patients has been investigated in many researches. For these patients determination of prognostic factors helps generating multimodal therapy protocols. For this purpose, in the Baskent University Medical School, Neurosurgery Clinic, Adana Medical Research Center, specific characteristics of GBM patients who have surgery retrospectively investigated and factors which affect prognosis has been determined. Between January 2005 and January 2009, 59 patients (25 female, 34 male) who have GBM have been evaluated retrospectively. Mean follow-up period was 27.4 (+/-17.3) months. Headache (66.1%) was the most seen symptom. Time of diagnosis was 1-2 months for most of the patients (54.2%). Fifty-nine patients had 67 operations totally. Preoperative Karnofski Performance Scale (KPS) was >or=70 for 43 operations, or=70, for 26 operations KPSor=70 (P=0.0000) , postoperative KPS 2 was >or=70 (P=0.0000), type of tumor resection (P=0.00002), multiple operations (P=0.001), adjuvant RT (P=0.0000) and ConcT with adjuvant TMZ (P=0.0000) were all positive prognostic factors which extend the survival. After multivariate analysis, post operative KPS was >or=70 (P=0.003; OR:0.89; % 95 CI:0.83-0.96), type of resection (P=0.055; OR:0.37; % 95 CI:0.13-0.12) and multiple operations (P=0.042; OR:2.65; % 95 CI:1.03-6.82) were independent prognostic factors. When independent prognostic factors were examined ,median survival found out 7.8 months longer fort he patients whose postoperative KPS were >or=70, 5.7 months longer for the patients who had radical resection, 6.6 months longer for the patients who had multiple operations. Although patients who had ConcT with adjuvant TMZ had 1.7 months longer survival compared to patients who had only adjuvant RT, it was not determined as an independent prognostic factor.


    • 1 July 2009
      • Vol. 19  (3) , 256-9

    A rare but fatal case of granulomatous amebic encephalitis with brain abscess: the first case reported from Turkey.

    by Feyzi Birol Sarica, Kadir Tufan, Melih Cekinmez, Bülent Erdoğan, Mehmet Nur Altinörs

    The incidence of protozoal and helminthic infestations of the central nervous system (CNS) is less than 1%, but these infestations tend to follow a fatal course. They are more common among children, the elderly and immunocompromised individuals. CNS infections due to Entamoeba histolytica have been known for a long time. In recent years, especially in developing countries, there has been an increase in CNS infections due to free-living amebas (FLAs). Acute CNS infection due to Naegleria fowleri, which ends in death within 2-7 days, is termed primary amebic meningoencephalitis (PAM); subacute or chronic CNS infections due to Acanthamoeba spp, Balamuthia mandrillaris, and Sappinia diploidea, which occasionally cause cerebral abscess, are termed granulomatous amebic encephalitis (GAE). This paper presents a case of GAE with abscess formation in a 75-year-old male patient.


    • 1 June 2009
      • Vol. 53  (2) , 63-6

    Paraparesis following straining accompanied by spontaneous thoracolumbar spinal epidural hematoma: a case report.

    by F Birol Sarica, K Tufan, M Cekinmez, O Sen, O Alkan, H Caner

    Spontaneous spinal epidural hematoma (SSEH) is a rare disease that requires emergency surgical intervention because it can cause serious and permanent neurological damage. Its etiology is related to coagulopathy, vascular malformation, hypertension, neoplasms, infections and idiopathic causes. It is frequently observed in the cervicothoracic and thoracolumbar regions. Inadequate spinal vascularization of the thoracolumbar junction increases the risk of spinal infarcts in lesions in this region. Therefore, prompt and effective surgical intervention is critical in patients with a thoracolumbar SSEH. We conclude that prognosis would be better than it is if patients with complete neurological damage were to undergo spinal decompression within the first 36 hours, and patients with incomplete neurological damage were operated on in the first 48 hours. We report a 71-year-old female patient with a history of aspirin use who developed paraparesis accompanied by SSEH following straining, and emphasize the importance of early surgical treatment.


    • 1 July 2008
      • Vol. 18  (3) , 236-40

    A non-bleeding complex intracerebral giant aneurysm case: case report.

    by Feyzi Birol Sarica, Melih Cekinmez, Kadir Tufan, Orhan Sen, Bülent Erdoğan, Mehmet Nur Altinörs

    An intracranial aneurysm with a diameter larger than 25 mm is considered a giant aneurysm (GA), and represent about 3-5% of all aneurysms. They are divided into two forms, specifically saccular and fusiform. Fusiform aneurysms are rare, making up only 1% of all intracranial aneurysms. They frequently involve the internal carotid artery (ICA) or the basilar or vertebral arteries, and rarely bleed. Treatment of huge aneurysms that have not bled is still controversial. Unlike the saccular huge aneurysms that lead to death of 80% of the patients few years after diagnosis, fusiform huge aneurysms, particularly those presenting with mass effect, have a better prognosis. In this manuscript, we discuss the infrequently seen intracranial fusiform giant aneurysms in light of the pertinent literature.